Qiagen NV acquires Enzyme Solutions unit of Enzymatics
Executive Summary
Qiagen NV acquired the Enzyme Solutions unit of Enzymatics Inc. for $114.2mm in cash (manufactures enzymes for next-generation sequencing (NGS)). The deal is expected to add approximately $20mm in incremental net sales to Qiagen in 2015, will be accretive to diluted EPS, and will allow the company to offer a complete NGS workflow.
Deal Industry
- Research, Analytical Equipment & Supplies
Deal Status
- Final
Deal Type
-
Acquisition
- Full Acquisition
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice